Virtual Screening for the Discovery of Microbiome β-Glucuronidase Inhibitors to Alleviate Cancer Drug Toxicity.

导出 OA

翻译打印收藏纠错

第一作者： Anup P,Challa

第一单位： Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee 37212, United States.;Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, Tennessee 37203, United States.;National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland 20850, United States.

作者： Anup P,Challa ^[1] ; Xin,Hu ^[2] ; Ya-Qin,Zhang ^[2] ; Jeffrey,Hymes ^[3] ; Bret D,Wallace ^[3] ; Surendra,Karavadhi ^[2] ; Hongmao,Sun ^[2] ; Samarjit,Patnaik ^[2] ; Matthew D,Hall ^[2] ; Min,Shen ^[2]

作者单位： Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee 37212, United States.;Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, Tennessee 37203, United States.;National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland 20850, United States. ^[1] National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland 20850, United States. ^[2] Symberix, Inc., 4819 Emperor Blvd., Suite 400, Durham, North Carolina 27703, United States. ^[3]

主题词抗肿瘤药(Antineoplastic Agents);癌症早期检测(Early Detection of Cancer);酶抑制剂(Enzyme Inhibitors);糖蛋白类(Glycoproteins);人类(Humans);肿瘤(Neoplasms)

DOI 10.1021/acs.jcim.1c01414

PMID 35357819

发布时间 2024-09-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交